In the second installment of this two-part series, Tableau’s Nate Nichols explores how agentic AI can enhance—not replace—clinicians by providing vital services for care teams, such as real-time transcription, EHR-integrated summaries, and smarter triage, that can free clinicians to focus on patients. The conversation covers patient-side benefits, barriers to adoption, practical first steps for pharma and health systems, and marketing in an agent-first world.
All content for Pharma Council - FutureHealth is the property of Advertising Research Foundation and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In the second installment of this two-part series, Tableau’s Nate Nichols explores how agentic AI can enhance—not replace—clinicians by providing vital services for care teams, such as real-time transcription, EHR-integrated summaries, and smarter triage, that can free clinicians to focus on patients. The conversation covers patient-side benefits, barriers to adoption, practical first steps for pharma and health systems, and marketing in an agent-first world.
There are around 1,068,000 practicing primary care and specialist physicians in the U.S. today, according to the nonprofit Kaiser Family Foundation, in addition to over 3 million nurses. While this is a sizable market for the pharma and health care industries, these medical professionals have different specialties, serve different communities, and practice in different ways. We take a look at how healthcare provider segmentation can help pharma marketers to best tailor their approach to reach...
Pharma Council - FutureHealth
In the second installment of this two-part series, Tableau’s Nate Nichols explores how agentic AI can enhance—not replace—clinicians by providing vital services for care teams, such as real-time transcription, EHR-integrated summaries, and smarter triage, that can free clinicians to focus on patients. The conversation covers patient-side benefits, barriers to adoption, practical first steps for pharma and health systems, and marketing in an agent-first world.
